CNBC Pro

Citi downgrades Merck to neutral, says drug pipeline struggles will hold stock back

Medicine pill is seen with Merck logo displayed on a screen in the background in this illustration photo taken in Poland on October 4, 2021.
NurPhoto | NurPhoto | Getty Images

Disappointing results for some major drugs has limited the upside for Merck's stock, according to Citi.

More In Street Calls

CNBC ProHere are Friday's biggest analyst calls: Gap, Apple, Tesla, CVS, Citigroup, Ulta & more
CNBC ProNeedham upgrades Boston Scientific to buy, says company can fend off competition
CNBC ProJefferies upgrades Ulta to buy, says strong earnings are the 'all clear' for a recovery